Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: A Hellenic Cooperative Oncology Group (HeCOG) study

Author：                                  

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.27, Iss.1, 2012-01, pp. : 216-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: A Hellenic Cooperative Oncology Group (HeCOG) phase II study

By Makatsoris Thomas   Papakostas Pavlos   Kalofonos Haralabos   Xanthakis Ioannis   Tsavdaridis Dimitrios   Aravantinos Gerasimos   Gogas Helen   Klouvas George   Kosmidis Paris   Pectasides Dimitrios   Fountzilas George  

Medical Oncology, Vol. 24, Iss. 3, 2007-09 ,pp. : 301-307

Humana Press, Inc

Access to resources Recommend Favorite

Adjuvant Dose-Dense Sequential Chemotherapy with Epirubicin, CMF and Weekly Paclitaxel in Patients with Resected High-Risk Breast Cancer: A Hellenic Cooperative Oncology Group (HeCOG) Study

By Papadimitriou Christos   Papakostas Pavlos   Timotheadou Eleni   Aravantinos Gerasimos   Bamias Aristotelis   Fountzilas George  

Cancer Investigation, Vol. 26, Iss. 5, 2008-06 ,pp. : 491-498

Informa Healthcare

Access to resources Recommend Favorite

Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study

By Christodoulou Christos   Bafaloukos Dimitrios   Linardou Helen   Aravantinos Gerassimos   Bamias Aristotelis   Carina Maria   Klouvas George   Skarlos Dimosthenis  

Journal of Neuro-Oncology, Vol. 71, Iss. 1, 2005-01 ,pp. : 61-65

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial

By Pliarchopoulou K.   Kalogeras K.   Kronenwett R.   Wirtz R.   Eleftheraki A.   Batistatou A.   Bobos M.   Soupos N.   Polychronidou G.   Gogas H.   Samantas E.   Christodoulou C.   Makatsoris T.   Pavlidis N.   Pectasides D.   Fountzilas G.  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 245-255

Springer Publishing Company

Access to resources Recommend Favorite

Paclitaxel by 3-h Infusion and Carboplatin in Anthracycline-resistant Advanced Breast Cancer. A Phase II Study Conducted by the Hellenic Cooperative Oncology Group

By Fountzilas G.   Athanassiadis A.   Kalogera-Fountzila A.   Aravantinos G.   Bafaloukos D.   Briasoulis E.   Dombros N.   Ioannidis I.   Pavlidis N.   Kosmidis P.   Skarlos D.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1893-1895

Elsevier

Access to resources Recommend Favorite